 InspireMD, Inc. NYSE American: NSPR, developer of the CGuardTM Embolic Prevention System EPS for the prevention of stroke caused by carotid artery disease, today announced that a successful live case featuring CGuardTM EPS was presented at the international LINC conference 2020, which is being held January 28 31 in Leipzig, Germany. 